Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Maglie

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Opinion in Pharmacology|February 16, 2019
Pharmacological advances in pemphigoidRoberto Maglie, Michael Hertl
The British Journal of Dermatology|May 16, 2026
Patient phenotyping to guide therapeutic strategies in bullous pemphigoid: towards personalized medicine in autoimmune bullous diseasesRoberto Maglie, Emiliano Antiga
Journal of the European Academy of Dermatology and Venereology : JEADV|June 28, 2024
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid'Roberto Maglie, Emiliano Antiga
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 25, 2017
A case of blood sweating: hematohidrosis syndromeRoberto Maglie, Marzia Caproni
International Journal of Dermatology|June 10, 2020
Nivolumab-induced erosive pustular dermatosis of the scalpRoberto Maglie, Emiliano Antiga
Journal of the American Academy of Dermatology|September 2, 2019
Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia"Roberto Maglie, Vieri Grandi, Emiliano Antiga
The Journal of Investigative Dermatology|December 11, 2020
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?Emiliano Antiga, Roberto Maglie, Paolo Fabbri
Journal of the American Academy of Dermatology|January 9, 2018
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis"Roberto Maglie, Emiliano Antiga, Marzia Caproni
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 9, 2025
Gluten-related skin disorders: clinical presentation, diagnostic and treatmentsDario Didona, Roberto Maglie, Farzan Solimani
Italian Journal of Dermatology and Venereology|October 5, 2020
B-cell targeted therapies in pemphigusRoberto Maglie, Emiliano Antiga, Aimee S Payne
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Opinion in Pharmacology|February 16, 2019
Pharmacological advances in pemphigoidRoberto Maglie, Michael Hertl
The British Journal of Dermatology|May 16, 2026
Patient phenotyping to guide therapeutic strategies in bullous pemphigoid: towards personalized medicine in autoimmune bullous diseasesRoberto Maglie, Emiliano Antiga
Journal of the European Academy of Dermatology and Venereology : JEADV|June 28, 2024
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid'Roberto Maglie, Emiliano Antiga
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 25, 2017
A case of blood sweating: hematohidrosis syndromeRoberto Maglie, Marzia Caproni
International Journal of Dermatology|June 10, 2020
Nivolumab-induced erosive pustular dermatosis of the scalpRoberto Maglie, Emiliano Antiga
Journal of the American Academy of Dermatology|September 2, 2019
Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia"Roberto Maglie, Vieri Grandi, Emiliano Antiga
The Journal of Investigative Dermatology|December 11, 2020
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?Emiliano Antiga, Roberto Maglie, Paolo Fabbri
Journal of the American Academy of Dermatology|January 9, 2018
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis"Roberto Maglie, Emiliano Antiga, Marzia Caproni
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 9, 2025
Gluten-related skin disorders: clinical presentation, diagnostic and treatmentsDario Didona, Roberto Maglie, Farzan Solimani
Italian Journal of Dermatology and Venereology|October 5, 2020
B-cell targeted therapies in pemphigusRoberto Maglie, Emiliano Antiga, Aimee S Payne
Pageof 9